๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

SGLT2 Inhibitors: A New Emerging Therapeutic Class in the Treatment of Type 2 Diabetes Mellitus

โœ Scribed by Ghosh, Raktim Kumar; Ghosh, Samhati Mondal; Chawla, Shalini; Jasdanwala, Sarfaraz Abdeli

Book ID
120230004
Publisher
Sage Publications
Year
2012
Tongue
English
Weight
139 KB
Volume
52
Category
Article
ISSN
0091-2700

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The SGLT2 Inhibitor Empagliflozin for th
The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review
โœ McGill, Janet B. ๐Ÿ“‚ Article ๐Ÿ“… 2014 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 617 KB

## Introduction The treatment of type 2 diabetes mellitus (T2DM) continues to pose challenges for clinicians and patients. The dramatic rise in T2DM prevalence, which has paralleled the rise in obesity, has strained the healthcare system and prompted the search for therapies that not only effective